6/4/2021 Risk of cancer-specific death for patients diagnosed with neuroendocrine tumors: a population-based analysis Hallet J, Law C, Singh S, Mahar A, Myrehaug S, Zuk V, Zhao H, Chan W, Assal A, Coburn N. J Natl Compr Canc Netw. 2021; 19(8):935-44. Epub 2021 Jun 4. DOI: https://doi.org/10.6004/jnccn.2020.7666
3/24/2021 Influence of chronic comorbidities on periodic colorectal cancer screening participation: a population-based cohort study Bhatia D, Sutradhar R, Tinmouth J, Singh S, Lau C, Lipscombe LL. Prev Med. 2021; 147:106530. Epub 2021 Mar 24. DOI: https://doi.org/10.1016/j.ypmed.2021.106530
1/6/2021 Patient reported symptom burden as a predictor of emergency department use and unplanned hospitalization in head and neck cancer: a longitudinal population based study Noel C, Sutradhar R, Zhao H, Delibasic V, Forner D, Irish JC, Kim J, Husain Z, Mahar A, Karam I, Enepekides DJ, Chan KKW, Singh S, Hallet J, Coburn NG, Eskander A. J Clin Oncol. 2021; 39(6):675-84. Epub 2021 Jan 6. DOI: https://doi.org/10.1200/JCO.20.01845
The Globe and Mail11/5/2018Article Additional screening for late-stage cancer patients has little benefit, study says